New research published in Nature Cancer has identified iron accumulation as a trigger for the destruction of CAR-T immune cells. We explore what this unexpected finding could mean for the future of lung cancer treatment.

The EU is consulting on new restrictions on PFAS chemicals, also known as “forever chemicals.” Lung Cancer Europe explains what the proposed regulation involves, why it matters for medicine supply, and how we are engaging with the process.

RET fusions drive around 1 to 2% of all lung cancers. For years, treatment options were limited. That has changed. New data from ASCO 2026 show that targeted therapies now span multiple stages of RET fusion-positive lung cancer, with next-generation options already in development. Lung Cancer Europe explains the science, the treatments, and what to ask your oncologist.

Last week, two things converged. The world's largest oncology conference brought thousands of researchers to Chicago. And Nature published an article declaring lung cancer in women a distinct disease. The timing was not coincidental.

Lung Cancer Europe President Debra Montague is among more than 490 healthcare experts, researchers, academics, and patient advocates calling for a dedicated, ring-fenced health budget in the EU’s next long-term budget. Here is what the MFF 2028-2034 negotiations mean for people living with lung cancer across Europe.

Tobacco is the single largest preventable cause of lung cancer in Europe. But lung cancer can affect anyone, including people who have never smoked. On World No Tobacco Day 2026, Lung Cancer Europe calls for stronger EU tobacco regulation to protect young people from targeted marketing, and compassionate support for people who want to quit.